Results
Symbiotec Pharmalab Q1FY27 Steady 6% Sales Growth
Symbiotec Pharmalab Limited disclosed its Q1FY27 unaudited results via an investor presentation following its September 2026 IPO, which raised Rs. 1,757 Cr.
Q1 sales grew 6% YoY with a 9% EBITDA growt
